ARVN stock

Arvinas Inc (ARVN) stock news · rev $262.6M

Arvinas Inc (ARVN) is a biotechnology company listed on US.

This ARVN news page leads with what Arvinas Inc filed — not a scraped headline mill.

No cached 8-K sentence for ARVN yet. We will not pad this page with generic market recap.

Latest reported ARVN revenue for 2025-12-31 was $262.6M. Net income was -$80.8M. Revenue was down 0.3% from 2024-12-31 to 2025-12-31. ARVN currently screens at market cap $478.7M.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the ARVN stock page; for the tape open the quote page.

ARVN stock news FAQ

What are ARVN's latest revenue and net income?

Latest cached Arvinas Inc (ARVN) revenue for Dec 31, 2025 was $262.6M. Net income was -$80.8M. Statements: https://lician.com/financials/arvn

How did ARVN revenue change from the prior cached period?

Cached Arvinas Inc (ARVN) revenue was down 0.3% from $263.4M (Dec 31, 2024) to $262.6M (Dec 31, 2025). Statements: https://lician.com/financials/arvn

What is ARVN's market cap?

Arvinas Inc (ARVN) market cap is $478.7M on the latest cached fundamentals snapshot.

What kind of company is ARVN?

Arvinas Inc (ARVN) is a biotechnology company listed on US.

Where is ARVN stock news listed?

Cached stock news for Arvinas Inc (ARVN) is listed at https://lician.com/news/arvn. Filings: https://lician.com/sec/arvn

Not investment advice.

Full ARVN analysis